Live Breaking News & Updates on Offset Pressure

Stay updated with breaking news from Offset pressure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Worldwide CNS Therapeutics Industry to 2025 - Awareness Campaigns Launched by Pharma Companies to Benefit the Market


Share this article
Share this article
ResearchAndMarkets.com s offering.
The global market for CNS Therapeutics is projected to reach US$137.7 billion by 2025, driven by the urgent need to address the unmet medical needs of neurological disorders. Diseases of the brain and mind range from epilepsy, stroke, migraine, Alzheimer`s, Parkinson`s, dementia, multiple sclerosis, brain injuries, neuroinfections, schizophrenia, psychosis and other mental disorders. With unmet needs continuing to persist, societal and healthcare burden continues to increase.
Stroke and infections such as meningitis and encephalitis continue to be the leading cause of disability worldwide, pushing up the cost of nursing care, hospice and bringing down quality of life. The unmet needs are evident in all phases of drug development i.e. identification of therapeutic targets; optimization of lead compounds; gaps in toxicity and pharmacokinetics studies; and slow resolution of ethical issues, amon ....

United States , United Kingdom , Effexor Venlafaxine , Epidiolex Cannabidiol , Purdue Pharma , Eli Lilly Emgality , Risperdal Consta , Eli Lilly , Invega Sustenna , Laura Wood , Age Group , Lack Of Evidence , A New Research Demonstrates Effectiveness Of Gluconate , Janssen Pharmaceuticals Inc , Astrazeneca Plc , Teva Pharmaceutical Industries Ltd , Merck Co Inc , Pfizer Inc , Pharma Companies , Abbvie Inc , Sunovion Pharmaceuticals Inc , Otsuka Pharmaceutical Co Ltd , Fabre Kramer Pharmaceuticals Inc , Alkermes Plc , Roche Ltd , Neurocrine Biosciences Inc ,

Global CNS Therapeutics Industry (2020 to 2025) - Increased Spending on Prescription Drugs Bodes Well for the Market


Press release content from Business Wire. The AP news staff was not involved in its creation.
Global CNS Therapeutics Industry (2020 to 2025) - Increased Spending on Prescription Drugs Bodes Well for the Market - ResearchAndMarkets.com
April 12, 2021 GMT
The global market for CNS Therapeutics is projected to reach US$137.7 billion by 2025, driven by the urgent need to address the unmet medical needs of neurological disorders. Diseases of the brain and mind range from epilepsy, stroke, migraine, Alzheimer`s, Parkinson`s, dementia, multiple sclerosis, brain injuries, neuroinfections, schizophrenia, psychosis and other mental disorders. With unmet needs continuing to persist, societal and healthcare burden continues to increase. ....

United States , Purdue Pharma , Eli Lilly , Bristol Myers Squibb , Laura Wood , Glaxosmithkline Plc , Janssen Pharmaceuticals Inc , Astrazeneca Plc , Teva Pharmaceutical Industries Ltd , Merck Co Inc , Shire Plc , Pharma Companies , Pfizer Inc , Abbvie Inc , Alkermes Plc , Roche Ltd , Endo Pharmaceuticals Inc , Neurocrine Biosciences Inc , Allergan Plc , Takeda Pharmaceutical Co Ltd , Office Hours Call , Otsuka Pharmaceutical Co , Eisai Co Ltd , Pharma Companies To Benefit The Market , E St Office Hours Call , Sumitomo Dainippon Pharma Co Ltd ,